Literature DB >> 31155486

Predictors of Overtesting in Pulmonary Embolism Diagnosis.

Safiya Richardson1, Eugene Lucas2, Stuart L Cohen2, Meng Zhang2, Guang Qiu2, Sundas Khan2, Thomas McGinn2.   

Abstract

BACKGROUND: The benefits of computed tomography pulmonary angiography (CTPA) for pulmonary embolism (PE) diagnosis must be weighed against its risks, radiation-induced malignancy, and contrast-induced nephropathy. Appropriate use of CTPA can be assessed by monitoring yield, the percentage of tests positive for PE. We identify factors that are associated low CTPA yield, which may predict overtesting.
METHODS: This was a retrospective cohort study of six emergency departments between June 2014 and February 2017. The electronic health record was queried for CTPAs ordered for adult patients in the emergency department. We assessed the following patient factors: age, gender, body mass index, number of comorbidities, race, and ethnicity, provider factors: type (resident, fellow, attending, physician assistant) and environment factors: test time of day, season of visit, and crowdedness of the department.
RESULTS: A total of 14,782 CTPAs were reviewed, of which 1366 were found to be positive for PE, resulting in an overall CTPA yield of 9.24%. Provider type was not associated with a difference in yield. Testing was less likely to be positive in younger patients, females, those with lower body mass indexes and those identifying as Asian or Hispanic. Testing was also less likely to be positive when ordered during the overnight shift and during the winter and spring seasons.
CONCLUSION: Our study identified several patient and environmental factors associated with low CTPA yield suggesting potential targets for overtesting. Targeting education and clinical decision support to assist providers in these circumstances may meaningfully improve yields.
Copyright © 2019 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Computed tomography pulmonary angiography; Electronic health record; Health informatics; Pulmonary embolism; Quality improvement

Year:  2019        PMID: 31155486      PMCID: PMC6885095          DOI: 10.1016/j.acra.2019.04.018

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  41 in total

1.  Effectiveness and acceptability of a computerized decision support system using modified Wells criteria for evaluation of suspected pulmonary embolism.

Authors:  Frank S Drescher; Sharad Chandrika; Ian D Weir; Jeffrey T Weintraub; Lewis Berman; Ronald Lee; Patricia D Van Buskirk; Yun Wang; Adeshola Adewunmi; Jonathan M Fine
Journal:  Ann Emerg Med       Date:  2010-11-02       Impact factor: 5.721

2.  Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996.

Authors:  Richard H White; Hong Zhou; Susan Murin; Danielle Harvey
Journal:  Thromb Haemost       Date:  2005-02       Impact factor: 5.249

3.  U.S. trends in computed tomography use and diagnoses in emergency department visits by patients with symptoms suggestive of pulmonary embolism, 2001-2009.

Authors:  Lisa B Feng; Jesse M Pines; Hussain R Yusuf; Scott D Grosse
Journal:  Acad Emerg Med       Date:  2013-10       Impact factor: 3.451

4.  Pulmonary embolism at CT angiography: implications for appropriateness, cost, and radiation exposure in 2003 patients.

Authors:  Mark D Mamlouk; Eric vanSonnenberg; Rishi Gosalia; David Drachman; Daniel Gridley; Jesus G Zamora; Giovanna Casola; Sanford Ornstein
Journal:  Radiology       Date:  2010-06-15       Impact factor: 11.105

5.  Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).

Authors:  Aaron R Folsom; Pamela L Lutsey; Vijay Nambi; Christopher R deFilippi; Susan R Heckbert; Mary Cushman; Christie M Ballantyne
Journal:  Vasc Med       Date:  2014-02       Impact factor: 3.239

6.  Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer.

Authors:  Rebecca Smith-Bindman; Jafi Lipson; Ralph Marcus; Kwang-Pyo Kim; Mahadevappa Mahesh; Robert Gould; Amy Berrington de González; Diana L Miglioretti
Journal:  Arch Intern Med       Date:  2009-12-14

7.  Projected cancer risks from computed tomographic scans performed in the United States in 2007.

Authors:  Amy Berrington de González; Mahadevappa Mahesh; Kwang-Pyo Kim; Mythreyi Bhargavan; Rebecca Lewis; Fred Mettler; Charles Land
Journal:  Arch Intern Med       Date:  2009-12-14

8.  Prospective study of BMI and the risk of pulmonary embolism in women.

Authors:  Christopher Kabrhel; Raphaëlle Varraso; Samuel Z Goldhaber; Eric B Rimm; Carlos A Camargo
Journal:  Obesity (Silver Spring)       Date:  2009-04-16       Impact factor: 5.002

9.  Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census.

Authors:  Paul D Stein; Fadi Kayali; Ronald E Olson; Creagh E Milford
Journal:  Am J Med       Date:  2004-04-01       Impact factor: 4.965

10.  RESPECT-ED: Rates of Pulmonary Emboli (PE) and Sub-Segmental PE with Modern Computed Tomographic Pulmonary Angiograms in Emergency Departments: A Multi-Center Observational Study Finds Significant Yield Variation, Uncorrelated with Use or Small PE Rates.

Authors:  David Mountain; Gerben Keijzers; Kevin Chu; Anthony Joseph; Catherine Read; Gabriel Blecher; Jeremy Furyk; Chrianna Bharat; Karthik Velusamy; Andrew Munro; Kylie Baker; Frances Kinnear; Ahses Mukherjee; Gina Watkins; Paul Buntine; Georgia Livesay; Daniel Fatovich
Journal:  PLoS One       Date:  2016-12-05       Impact factor: 3.240

View more
  1 in total

1.  Variability in practice patterns among emergency physicians in the evaluation of patients with a suspected diagnosis of pulmonary embolism.

Authors:  Leila Salehi; Prashant Phalpher; Marc Ossip; Christopher Meaney; Rahim Valani; Mathew Mercuri
Journal:  Emerg Radiol       Date:  2019-11-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.